Ngā hua rapu kaituhi :: APM

1

Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot study mā Markus Cornberg, Johannes Hadem, Eva Herrmann, Frank Schuppert, Hartmut Schmidt, Markus Reiser, Oliver Marschal, Martín Steffen, Michael P. Manns, Heiner Wedemeyer

I whakaputaina 2005

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C mā Markus Reiser, Holger Hinrichsen, Yves Benhamou, H. W. Reesink, Heiner Wedemeyer, C. Avendaño, N. Riba, Chan‐Loi Yong, Gerhard Nehmiz, Gerhard Steinmann

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Comprehensive Analysis of CD8<sup>+</sup>-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities mā Georg M. Lauer, Kei Ouchi, Raymond T. Chung, Tam Nguyen, Cheryl L. Day, Deborah R. Purkis, Markus Reiser, Arthur Y. Kim, Michaela Lucas, Paul Klenerman, Bruce D. Walker

I whakaputaina 2002

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients mā Holger Hinrichsen, Yves Benhamou, Heiner Wedemeyer, Markus Reiser, Roel Sentjens, José Luís Calleja, Xavier Forns, Andreas Erhardt, Jens Crönlein, Ricardo L. Chaves, Chan‐Loi Yong, Gerhard Nehmiz, Gerhard Steinmann

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Analysis of the Evolutionary Forces in an Immunodominant CD8 Epitope in Hepatitis C Virus at a Population Level mā Christoph Neumann‐Haefelin, David N. Frick, Jing Jing Wang, Oliver G. Pybus, Shadi Salloum, Gagandeep Narula, Anna Eckart, Andrea Biezynski, Thomas Eiermann, Paul Klenerman, Sergei Viazov, Michael Roggendorf, Robert Thimme, Markus Reiser, Jörg Timm

I whakaputaina 2008

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection mā Georg M. Lauer, Eleanor Barnes, Michaela Lucas, Jörg Timm, Kei Ouchi, Arthur Y. Kim, Cheryl L. Day, Gregory K. Robbins, Deborah Casson, Markus Reiser, Geoffrey Dusheiko, Todd M. Allen, Raymond T. Chung, Bruce D. Walker, Paul Klenerman

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Detection of novel biomarkers of liver cirrhosis by proteomic analysis mā Christian Mölleken, Barbara Sitek, Corinna Henkel, Gereon Poschmann, Bence Sipos, Sebastian Wiese, Bettina Warscheid, Christoph E. Broelsch, Markus Reiser, Scott L. Friedman, Ida Tornøe, Anders Schlosser, Günter Klöppel, Wolff Schmiegel, Helmut E. Meyer, Uffe Holmskov, Kai Stühler

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Full-Breadth Analysis of CD8<sup>+</sup>T-Cell Responses in Acute Hepatitis C Virus Infection and Early Therapy mā Georg M. Lauer, Michaela Lucas, Jörg Timm, Kei Ouchi, Arthur Y. Kim, Cheryl L. Day, Julian Schulze zur Wiesch, Gláucia Paranhos‐Baccalà, Isabelle Sheridan, Deborah Casson, Markus Reiser, Rajesh T. Gandhi, Bin Li, Todd M. Allen, Raymond T. Chung, Paul Klenerman, Bruce D. Walker

I whakaputaina 2005

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment mā Andreas Erhardt, Katja Deterding, Yves Benhamou, Markus Reiser, Xavier Forns, Stanislas Pol, José Luís Calleja, Susanne Ross, Hans Christian Spangenberg, Javier García‐Samaniego, Michael Fuchs, Jaime Enríquez, Johannes Wiegand, Jerry O. Stern, K. Wu, George Kukolj, Martin Marquis, Pierre L. Beaulieu, Gerhard Nehmiz, Jürgen Steffgen

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled Trial mā Stephan Ehrhardt, Nan Guo, Rebecca Hinz, Stefanie Schoppen, Jürgen May, Markus Reiser, Maximilian Philipp Schroeder, Stefan Schmiedel, Martin Keuchel, Emil C. Reisinger, Andreas Langeheinecke, Andreas de Weerth, Marcus Schuchmann, Tom Schaberg, Sandra Ligges, Maria Eveslage, Ralf Matthias Hagen, Gerd Burchard, Ansgar W. Lohse, B. Ruf, Rainer Porschen, Guido Trenn, Trude Butterfaß‐Bahloul, Gudrun Wuerthwein, Frank Oeder, A Runge, Esther Klauss, Nina Hansen-Rosenblatt, T Werner, Kornelius Schulze, Benno Kreuels, Guido Schäfer, Peter Hübener, Annette Hennigs, Claudia Beisel, Dorothee Fischer-Brügge, Katharina Zimmermann‐Fraedrich, Claudia Röder, Nadine Grigo, Armin Riecke, Helmut Schreckenbauer, Christoph Josef Hemmer, Sebastian Klammt, Hilte Geerdes‐Fenge, Silvius Frimmel, Jens M. Kittner, Johannes Rey, Jörn M. Schattenberg, F Thieringer, Rudolf Schmits, Daniel Grandt, Philipp Martin Büch, Alexander Klebert, Marc Andreas Mittag, Sybille Lehnen, Daniel Tiefengraber, K Radecke, I. Hering, W. Zeller, Lisa Rundt, L. Brandt, Peter Baltes, Dani Dajani, Niehls Kurniawan, Carola Pflüger, Nassim Behjat, Ulrike Engel, M Unger

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: